loader image

Turning viruses
into anti-cancer molecular weapons

Our Mission

Guska's mission is to develop innovative oncolytic
virus-based cancer therapies that improve the quality of
life for patients suffering from some of the most
devastating forms of cancer.

Designing viruses
to fight cancer

Solution

Guska is developing synthetic RNA oncolytic virus therapy that delivers powerful and safe immunostimulatory effects. Our approach targets cancer directly, providing a more effective and less harmful alternative. By addressing the key challenges of cancer therapy, we aim to offer patients a promising solution that minimizes side effects while maximizing treatment efficacy.

Our Approach

In Guska, we developed synthetic RNA oncolytic virus therapies designed to deliver potent and safe immunostimulatory effects. By precisely targeting and eliminating cancer cells while preserving healthy tissue, our innovative approach offers a more effective and less harmful alternative to traditional treatments. Beyond direct cancer targeting, our therapies stimulate a robust immune response, empowering the body to fight tumors more effectively and paving the way for improved patient outcomes.

Our Vision

Lorem ipsum dolor sit amet consectetur adipiscing elit iaculis montes massa ultricies eleifend feugiat, eget vitae leo ornare interdum malesuada fringilla blandit senectus suspendisse volutpat. Sollicitudin facilisis nascetur fusce sodales class mi nec mattis habitasse

Our Team
Members

Great things Happen when
we work together.

Guska Team

Pilar Moreno, PhD

Co-Founder
COO

LAB Staff

Fabián Aldunate

Medical Doctor
Biochemist
MSc in Biological Sciences

Joaquín Hurtado

Biochemist
MSc in Biological Sciences

Paula Perbolianachis

Biologist
MSc in Biological Sciences

Juan Gandioli

Biotechnology
Engineer

Manuela Machado

Biotechnology
Engineer

Get in Touch